Priorities for healthcare research: funding, workforce and the future of Academic Health Science Networks
Morning, Tuesday, 4th July 2017
Central London
THIS EVENT IS CPD CERTIFIED
Guests of Honour
Dr Declan Mulkeen, Chief of Strategy, Medical Research Council
Professor Jonathan Montgomery, Chair, Health Research Authority
Dr Tony Soteriou, Deputy Director and Head of NHS Research Faculty, Infrastructure and Growth,Science, Research and Evidence, Department of Health
Delegates at this conference will assess the future of healthcare research in England - including the impact of the UK leaving the European Union.
Attendees will discuss priorities for funding following the Department of Health announcement of further investment for healthcare research and clinical research facilities. They will also consider the impact of Brexit on the research workforce and regulation, as well as next steps for collaboration between the NHS, academia and industry in light of the Academic Health Science Networks' (AHSNs) current 5-year license expiring in 2018.
Further sessions focus on progress on the 100,000 Genomes Project and stratified medicine, key issues around the use of data and the opportunities for public participation in research and clinical trials
Morning, Tuesday, 4th July 2017
Central London
THIS EVENT IS CPD CERTIFIED
Guests of Honour
Dr Declan Mulkeen, Chief of Strategy, Medical Research Council
Professor Jonathan Montgomery, Chair, Health Research Authority
Dr Tony Soteriou, Deputy Director and Head of NHS Research Faculty, Infrastructure and Growth,Science, Research and Evidence, Department of Health
Delegates at this conference will assess the future of healthcare research in England - including the impact of the UK leaving the European Union.
Attendees will discuss priorities for funding following the Department of Health announcement of further investment for healthcare research and clinical research facilities. They will also consider the impact of Brexit on the research workforce and regulation, as well as next steps for collaboration between the NHS, academia and industry in light of the Academic Health Science Networks' (AHSNs) current 5-year license expiring in 2018.
Further sessions focus on progress on the 100,000 Genomes Project and stratified medicine, key issues around the use of data and the opportunities for public participation in research and clinical trials
